San Francisco, CA, United States of America

Sabine Mueller


Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sabine Mueller: Innovator in Tumor Treatment and Visualization

Introduction

Sabine Mueller is a prominent inventor based in San Francisco, CA, known for her groundbreaking work in the field of tumor treatment and visualization. With a total of 4 patents, her contributions have significantly advanced the understanding and management of brain tumors.

Latest Patents

Her latest patents focus on the use of biomolecular targets in the treatment and visualization of tumors. One of her notable inventions relates to a protein that is differentially expressed in primary brain tumor tissues compared to normal brain tissues. This protein serves as a biomolecular target for tumor treatment therapies. Additionally, her work includes immunotherapeutic and immunoimaging agents that specifically bind to identified brain tumor target proteins. Another patent emphasizes the use of proteins that are differentially expressed in primary brain tumor tissues for treatment therapies, providing compounds and pharmaceutically acceptable compositions for administration.

Career Highlights

Throughout her career, Sabine has worked with notable companies such as Agy Therapeutics, Inc. and Medarex Inc. Her innovative approaches have garnered attention in the medical community, particularly in the realm of cancer research.

Collaborations

Some of her coworkers include Daniel J Chin and Mirella Gonzalez-Zulueta, who have collaborated with her on various projects aimed at enhancing tumor treatment methodologies.

Conclusion

Sabine Mueller's contributions to the field of tumor treatment and visualization exemplify her dedication to advancing medical science. Her innovative patents and collaborations continue to inspire future research and development in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…